| Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation CN Kotton, D Kumar, AM Caliendo, A Åsberg, S Chou, L Danziger-Isakov, ... Transplantation 96 (4), 333-360, 2013 | 871 | 2013 |
| Immunobiology of human cytomegalovirus: from bench to bedside T Crough, R Khanna Clinical microbiology reviews 22 (1), 76-98, 2009 | 841 | 2009 |
| Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments MK Gandhi, R Khanna The Lancet infectious diseases 4 (12), 725-738, 2004 | 807 | 2004 |
| The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation. HA Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L Transplantation, 2018 | 798* | 2018 |
| International consensus guidelines on the management of cytomegalovirus in solid organ transplantation CN Kotton, D Kumar, AM Caliendo, A Åsberg, S Chou, DR Snydman, ... Transplantation 89 (7), 779-795, 2010 | 681 | 2010 |
| Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. R Khanna, SR Burrows, MG Kurilla, CA Jacob, IS Misko, TB Sculley, ... The Journal of experimental medicine 176 (1), 169-176, 1992 | 476 | 1992 |
| Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection N Khan, A Hislop, N Gudgeon, M Cobbold, R Khanna, L Nayak, ... The Journal of Immunology 173 (12), 7481-7489, 2004 | 422 | 2004 |
| Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers R Elkington, S Walker, T Crough, M Menzies, J Tellam, M Bharadwaj, ... Journal of virology 77 (9), 5226-5240, 2003 | 406 | 2003 |
| Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease R Khanna, S Bell, M Sherritt, A Galbraith, SR Burrows, L Rafter, B Clarke, ... Proceedings of the National Academy of Sciences 96 (18), 10391-10396, 1999 | 370 | 1999 |
| An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. SR Burrows, R Khanna, JM Burrows, DJ Moss The Journal of experimental medicine 179 (4), 1155-1161, 1994 | 322 | 1994 |
| HLA-B27–restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class i peptide loading CA Peh, SR Burrows, M Barnden, R Khanna, P Cresswell, DJ Moss, ... Immunity 8 (5), 531-542, 1998 | 319 | 1998 |
| Immune regulation in Epstein-Barr virus-associated diseases R Khanna, SR Burrows, DJ Moss Microbiological reviews 59 (3), 387-405, 1995 | 307 | 1995 |
| Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith, S Elliott, D Gill, ... Blood 108 (7), 2280-2289, 2006 | 283 | 2006 |
| Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases R Khanna, SR Burrows Annual Reviews in Microbiology 54 (1), 19-48, 2000 | 269 | 2000 |
| G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation P Murat, J Zhong, L Lekieffre, NP Cowieson, JL Clancy, T Preiss, ... Nature chemical biology 10 (5), 358-364, 2014 | 251 | 2014 |
| Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and … M Rowe, R Khanna, CA Jacob, V Argaet, A Kelly, S Powis, M Belich, ... European journal of immunology 25 (5), 1374-1384, 1995 | 250 | 1995 |
| Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype‐restricted immune … R Khanna, SR Burrows, J Nicholls, LM Poulsen European journal of immunology 28 (2), 451-458, 1998 | 224 | 1998 |
| Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies A Bar-Or, MP Pender, R Khanna, L Steinman, HP Hartung, T Maniar, ... Trends in molecular medicine 26 (3), 296-310, 2020 | 220 | 2020 |
| Epstein–Barr virus‐associated Hodgkin's lymphoma MK Gandhi, JT Tellam, R Khanna British journal of haematology 125 (3), 267-281, 2004 | 213 | 2004 |
| BK polyomavirus: clinical aspects, immune regulation, and emerging therapies GR Ambalathingal, RS Francis, MJ Smyth, C Smith, R Khanna Clinical microbiology reviews 30 (2), 503-528, 2017 | 206 | 2017 |
Scott R BurrowsQueensland Institute of Medical ResearchVerified email at qimr.edu.au
